Study Stopped
SARS-CoV-2 coronavirus outbreak and end of funding
Assessment of Plaque Vulnerability Using a Novel Technique: Multi-spectral PhotoAcoustic Imaging.
(CVENT-PAI)
1 other identifier
observational
25
1 country
1
Brief Summary
Identification of intraplaque haemorrhage using MRI is technically demanding and sometimes uncomfortable. Photoacoustic imaging is a new non-invasive technique combining multi-wavelength infrared laser light and ultrasound imaging, able to discriminate blood and other components in the tissues. The measurement by the multi-spectral photoacoustic imaging is likely to be more acceptable and therefore could replace MRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 17, 2020
CompletedFirst Submitted
Initial submission to the registry
February 18, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedFebruary 21, 2021
February 1, 2021
1.1 years
February 18, 2021
February 18, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the device
The primary outcome is to evaluate the ability of the experimental device to visualize hemorrhage within the plaque. The primary endpoint will therefore be concordance with histology and plaque analysis (ex-vivo reference method) and MRI (invivo reference method).
18 month
Secondary Outcomes (1)
Evaluation of anatomical concordance
18 month
Eligibility Criteria
The project involves patients with atherosclerotic plaques (either symptomatic or not).
You may qualify if:
- Presence of at least one carotid plaque with a degree of stenosis 70% (NASCET), indication to surgery (endarterectomy),
- Patients with favourable anatomy criteria :
- x Cranio-caudal length of normal or long neck x Cervical adiposity weak or absent x Carotid bifurcation in usual situation (at the level of the mandibular angle or lower) x Normal genicity of subcutaneous tissues x Calcification of arterial moderate or absent
- Patients affiliated to the social health security system.
You may not qualify if:
- Refusal to participate,
- any concomitant chronic condition hampering the realization of ultrasound scanner or MRI (allergy to gel, intolerance or contraindication to gadolinium).
- Unstable patients with plaque claudication inducing procedure acceleration.
- Patients with unfavourable anatomy criteria :
- x Cranio-caudal length of the neck very short x Significant cervical adiposity x Carotid bifurcation higher than the mandibular angle x High echogenic subcutaneous tissue x Calcification marked arterialH2020-ICT-29-2016 no. 731771 Ethics requirements x Patients with fat necks, Presence of extensive calcifications at the site of the stenosis.
- Patients unable to consent.
- Pregnant woman or breastfeeding woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sainte-Anne Hospital
Paris, Île-de-France Region, 75014, France
Related Links
Biospecimen
atherosclerotic plaque
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 18, 2021
First Posted
February 21, 2021
Study Start
January 29, 2019
Primary Completion
March 17, 2020
Study Completion
March 17, 2020
Last Updated
February 21, 2021
Record last verified: 2021-02